Anti-inflammatory and protective effects of kallistatin in group A streptococcal infection

碩士 === 國立成功大學 === 微生物暨免疫學研究所 === 95 === The group A streptococcus (GAS) causes a variety of diseases, ranging from mild self-limiting infection to severe life-threatening infection, such as pharyngitis, tonsillitis, and tympanitis to necrotizing fasciitis, bacteremia, and streptococcus toxic shock s...

Full description

Bibliographic Details
Main Authors: Lu Shiou-Ling, 呂秀菱
Other Authors: 林以行
Format: Others
Language:zh-TW
Published: 2007
Online Access:http://ndltd.ncl.edu.tw/handle/83373735382141661280
id ndltd-TW-095NCKU0380004
record_format oai_dc
spelling ndltd-TW-095NCKU03800042015-10-13T16:45:44Z http://ndltd.ncl.edu.tw/handle/83373735382141661280 Anti-inflammatory and protective effects of kallistatin in group A streptococcal infection Kallistatin在A群鏈球菌感染的抗發炎保護效果之研究 Lu Shiou-Ling 呂秀菱 碩士 國立成功大學 微生物暨免疫學研究所 95 The group A streptococcus (GAS) causes a variety of diseases, ranging from mild self-limiting infection to severe life-threatening infection, such as pharyngitis, tonsillitis, and tympanitis to necrotizing fasciitis, bacteremia, and streptococcus toxic shock syndrome (STSS). The disease severity may be associated with the different bacterial serotype or depend on patient’s healthy condition. Previous clinical findings indicated that patients with sepsis had lower level of kallistatin protein. Kallistatin was originally found to be a tissue kallikrein-binding protein. But recent studies have shown that kallistatin may function independently of its interaction with tissue kallikrein. Kallistatin has some biological effects, such as anti-angiogenesis, anti-inflammation, and anti-oxidation and possesses beneficial effects in hypertensive, cardiovascular and renal diseases. However, the effects of kallistatin in microbial infection have not been explored. In this study, we transiently overexpressed kallistatin gene by hydrodynamic injection and investigated the protective effects of kallistatin in a mouse model of GAS infection. We found that kallistatin increased the survival rate of GAS-infected mice. The bacterial numbers and the inflammatory cytokines and chemokines in the local infection site and blood were lower in kallistatin-treated group than those in control groups. In contrast with control mice, kallistatin-treatment decreased neutrophil infiltration into the local infection site, while promoting neutrophil viability. In the histological analysis, the skin and liver tissue showed less damage after treatment with kallistatin compared to the control groups. Consequently, we will examine the biological function and therapeutic effect of kallistatin in GAS-infected mice. 林以行 2007 學位論文 ; thesis 51 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 國立成功大學 === 微生物暨免疫學研究所 === 95 === The group A streptococcus (GAS) causes a variety of diseases, ranging from mild self-limiting infection to severe life-threatening infection, such as pharyngitis, tonsillitis, and tympanitis to necrotizing fasciitis, bacteremia, and streptococcus toxic shock syndrome (STSS). The disease severity may be associated with the different bacterial serotype or depend on patient’s healthy condition. Previous clinical findings indicated that patients with sepsis had lower level of kallistatin protein. Kallistatin was originally found to be a tissue kallikrein-binding protein. But recent studies have shown that kallistatin may function independently of its interaction with tissue kallikrein. Kallistatin has some biological effects, such as anti-angiogenesis, anti-inflammation, and anti-oxidation and possesses beneficial effects in hypertensive, cardiovascular and renal diseases. However, the effects of kallistatin in microbial infection have not been explored. In this study, we transiently overexpressed kallistatin gene by hydrodynamic injection and investigated the protective effects of kallistatin in a mouse model of GAS infection. We found that kallistatin increased the survival rate of GAS-infected mice. The bacterial numbers and the inflammatory cytokines and chemokines in the local infection site and blood were lower in kallistatin-treated group than those in control groups. In contrast with control mice, kallistatin-treatment decreased neutrophil infiltration into the local infection site, while promoting neutrophil viability. In the histological analysis, the skin and liver tissue showed less damage after treatment with kallistatin compared to the control groups. Consequently, we will examine the biological function and therapeutic effect of kallistatin in GAS-infected mice.
author2 林以行
author_facet 林以行
Lu Shiou-Ling
呂秀菱
author Lu Shiou-Ling
呂秀菱
spellingShingle Lu Shiou-Ling
呂秀菱
Anti-inflammatory and protective effects of kallistatin in group A streptococcal infection
author_sort Lu Shiou-Ling
title Anti-inflammatory and protective effects of kallistatin in group A streptococcal infection
title_short Anti-inflammatory and protective effects of kallistatin in group A streptococcal infection
title_full Anti-inflammatory and protective effects of kallistatin in group A streptococcal infection
title_fullStr Anti-inflammatory and protective effects of kallistatin in group A streptococcal infection
title_full_unstemmed Anti-inflammatory and protective effects of kallistatin in group A streptococcal infection
title_sort anti-inflammatory and protective effects of kallistatin in group a streptococcal infection
publishDate 2007
url http://ndltd.ncl.edu.tw/handle/83373735382141661280
work_keys_str_mv AT lushiouling antiinflammatoryandprotectiveeffectsofkallistatiningroupastreptococcalinfection
AT lǚxiùlíng antiinflammatoryandprotectiveeffectsofkallistatiningroupastreptococcalinfection
AT lushiouling kallistatinzàiaqúnliànqiújūngǎnrǎndekàngfāyánbǎohùxiàoguǒzhīyánjiū
AT lǚxiùlíng kallistatinzàiaqúnliànqiújūngǎnrǎndekàngfāyánbǎohùxiàoguǒzhīyánjiū
_version_ 1717774492874309632